Protein Safeguards Muscle in Semaglutide Weight-Loss Therapy
Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women, and a high protein intake can mitigate this risk. Medscape Medical News
‘Ozempic mouth’ and ‘Ozempic teeth’ can be frightening — here’s the No. 1 way to protect your smile
“Some of these symptoms will not go away, but luckily, you won’t be taking the GLP-1 forever,” Dr. Elizabeth Walton said.
‘China’s Ozempic’ pioneer inks deal with JD Health for online distribution
Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, will leverage JD Health’s online distribution network as it seeks to grab a slice of a market that could be worth 40 billion yuan (US$5.6 billion) in a decade. The companies will collaborate on supply […]
Effective weight loss achieved even with inconsistent GLP-1 access
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
A Change in Diet Alone Already Benefits Your Cardiometabolic Health
Cardiometabolic diseases refer to a cluster of related conditions such as diabetes, kidney disease, fatty liver disease, heart attack, and stroke. And while medicine continues to advance, research shows that young adults in America do not have ideal behaviors that contribute to better health, increasing their risk for the conditions mentioned earlier.1 Since obesity is […]
Explained Interview | ‘After obesity, GLP-1 research focused on Alzheimer’s… hypothesis centres on its ability to reduce inflammation in brain… this is different from current approaches’
Post Content
FTC Penalizes NextMed $150k for Deceptive Weight-Loss Claims
What You Should Know: – The Federal Trade Commission (FTC) has reached a settlement with Southern Health Solutions, Inc., operating as Next Medical and NextMed, and its founders Robert Epstein and CEO Frank Leonardo III. – The FTC’s charges allege the telemedicine company used deceptive cost and weight loss claims, fake reviews, and undisclosed terms […]
Top Research Reports for Eli Lilly, Netflix & GE Aerospace
Monday, July 14, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Netflix, Inc. (NFLX) and GE Aerospace (GE), as well as two micro-cap stocks Willis Lease Finance Corp. (WLFC) and Flanigan’s Enterprises, […]
You don’t need to take drugs like Ozempic consistently to lose weight
People with disrupted access to GLP-1 drugs, like Ozempic, still seem to lose substantial amounts of weight
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.